November 9, 2018
A recent paper, published in October in JAMA Internal Medicine, detailed research in a large observational study exploring the risk of CKD among patients prescribed allopurinol for gout. The research was cited in Internal Medicine News and in the Highlights section of JAMA Network.
Vargas-Santos AB, Peloquin CE, Zhang Y, Neogi T. Association of chronic kidney disease with allopurinol use in gout treatment [published online October 8, 2018]. JAMA Intern Med. doi:10.1001/jamainternmed.2018.4463Google Scholar